Evidence map›Paper›PMID 36283065›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2022

[Cutaneous hyperpigmentation as a manifestation in acute on chronic liver failure].

Jesús Sebastián Rodríguez-Gutiérrez, Karen Montserrat Ramírez-Gómez, Maricela Omaña-Domínguez, Ana Lilia Ruelas-Villavicencio

Open access · greenAbstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jesús Sebastián Rodríguez-GutiérrezUniversidad Autónoma de Sinaloa, Centro de Investigación y Docencia en Ciencias de la Salud, Departamento de Dermatología. Culiacán, Sinaloa, México.ORCID 0000-0003-4010-0797
Karen Montserrat Ramírez-GómezSecretaría de Salud, Centro Dermatológico "Dr. Ladislao de la Pascua", Departamento de Dermatología. Ciudad de México, México.ORCID 0000-0002-6693-8005
Maricela Omaña-DomínguezUniversidad Autónoma de Sinaloa, Centro de Investigación y Docencia en Ciencias de la Salud, Departamento de Dermatología. Culiacán, Sinaloa, México.ORCID 0000-0001-7079-2320
Ana Lilia Ruelas-VillavicencioSecretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Departamento de Dermatología. Ciudad de México, México.ORCID 0000-0002-6886-2171
Universidad Autónoma de Sinaloa · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The acquired cutaneous pigmentation represents a little recognized clinical manifestation in liver disorders, both acute and chronic, and can occur in the exacerbation processes of preexisting hepatopathies, as in the context of acute-on-chronic liver failure. Several hypotheses about the increase in pigment at skin and mucous membranes have been developed; some try to explain it as a defect in the degradation of melanin with secondary accumulation at tissues; others, on the other hand, describe it as a consequence of the release of fibroblast growth factors like endothelial growth factor and hepatocyte growth factor, which are produced under the stimulation of liver regeneration and cause a melanogenesis stimulation. The aim of this article is to study pigmentary skin changes in the background of liver diseases. Clinical cases: We described two clinical cases of patients with acuteon chronic liver failure secondary to different clinical scenarios are presented, who have in common the development of acquired pigmentary skin changes. Conclusion: In hepatopathies, the cutaneous hyperpigmentation is a sign with unknown etiology, so further studies are required to know the accurate pathophysiology. Reporting this finding is useful for physicians, since timely identification can help in the early diagnosis of underlying liver diseases.

Indexed as

Acute-On-Chronic Liver FailureHyperpigmentationEndothelial Growth FactorsFibroblast Growth FactorsHepatocyte Growth FactorHumansMelaninsEndothelial Growth FactorsFibroblast Growth FactorsHepatocyte Growth FactorMelaninsAcute-On-Chronic Liver FailureHyperpigmentationLiver Diseases

Identifiers

PMID36283065
PMCPMC10396061
OpenAlexW4307432800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.